Rotavirus Vaccine Dramatically Reduces Hospital Visits For Rotavirus Gastroenteritis
Nov 21st 2008Drug InformationGastroIntestinal / Gastroentorology
New results presented at the ICAAC/IDSA* congress in Washington show that the pentavalent oral rotavirus vaccine RotaTeq®â? reduced hospitalisations and accident and emergency (A&E) department visits related to rotavirus gastroenteritis (RVGE) by up to 100%â?ˇ, consequently also avoiding the related costs§.1 The nationwide observational study, conducted in the USA by Sanofi Pasteur MSD’s parent company Merck &Co. Inc.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
